ACOG (American College of Obstetrician and Gynecologists)
Noninvasive prenatal testing that uses cell free fetal DNA from the plasma of pregnant women offers tremendous potential as a screening tool for fetal aneuploidy. Cell free fetal DNA testing should be an informed patient choice after pretest counseling and should not be part of routine prenatal laboratory assessment. Cell free fetal DNA testing should not be offered to low-risk women or women with multiple gestations because it has not been sufficiently evaluated in these groups. A negative cell free fetal DNA test result does not ensure an unaffected pregnancy. A patient with a positive test result should be referred for genetic counseling and should be offered invasive prenatal diagnosis for confirmation of test results.
ISPD (International Society of Prenatal Diagnosis)
ISPD recognizes that NIPT can be helpful as a screening test for women who are at high risk for Trisomy 21 with suitable genetic counseling. A positive test should be confirmed through invasive testing.
NSGC (National Society of Genetic Counselors)
NSGC supports NIPT as an option for patients whose pregnancies are considered to be increased risk for certain chromosome abnormities. NSGC urges that NIPT only be offered in the context of informed consent, education, and counseling by a qualified provider, such as a certified genetic counselor. Patients whose NIPT results are abnormal, or who have other factors suggestive of a chromosome abnormality, should receive genetic counseling and be given the option of standard confirmatory diagnostic testing.